Olga Haus

Cladribine, But Not Fludarabine, Added to Daunorubicin and Cytarabine During Induction Prolongs Survival of Patients With Acute Myeloid Leukemia: A Multicenter, Randomized Phase III Study

Jerzy Hołowiecki, Sebastian Grosicki, Sebastian Giebel et al. · Journal of Clinical Oncology · 2012 · 264 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

A high proportion of founder <i>BRCA1</i> mutations in Polish breast cancer families

Bohdan Górski, Anna Jakubowska, Tomasz Huzarski et al. · International Journal of Cancer · 2004 · 195 citations

Medicine, Genetics, Molecular Genetics +12

Clinical evolution, genetic landscape and trajectories of clonal hematopoiesis in SAMD9/SAMD9L syndromes

Sushree Sangita Sahoo, Victor B. Pastor, Charnise Goodings et al. · Nature Medicine · 2021 · 168 citations · Full text

Life Sciences, Genetics, Hematology +17

Breast cancer predisposing alleles in Poland

Bohdan Górski, Cezary Cybulski, Tomasz Huzarski et al. · Breast Cancer Research and Treatment · 2005 · 126 citations

Life Sciences, Genetics, Oncology +12

Addition of cladribine to daunorubicin and cytarabine increases complete remission rate after a single course of induction treatment in acute myeloid leukemia. Multicenter, phase III study

Sebastian Grosicki, Tadeusz Robak, Sławomira Kyrcz‐Krzemień et al. · Leukemia · 2004 · 126 citations · Full text

Medicine, Oncology, Pharmacology +9